ALVIO.PA PAR
Valerio Therapeutics S.A.
1W: -9.1%
1M: -26.2%
3M: +10.7%
YTD: +225.2%
1Y: +731.7%
3Y: +98.0%
€0.51 ($0.57)
-0.02 (-3.78%)
Weekly Expected Move ±6.9%
€0
€0
€1
€1
€1
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Income Trends
Revenue
$2M
-0.4% ▼
5Y CAGR: -16.0%
Gross Profit
$1M
+1.0% ▲
5Y CAGR: -20.1%
Operating Income
-$16M
+18.7% ▲
Net Income
-$24M
-17.6% ▼
EPS (Diluted)
$-0.16
-6.7% ▼
EBITDA
-$12M
+34.6% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $2M | $4M | $1M | $2M | $2M |
| YoY Growth | -58.6% | +128.7% | -64.5% | +24.7% | -0.4% |
| Cost of Revenue | $2M | $368K | $514K | $533K | $513K |
| Gross Profit | $1M | $4M | $929K | $1M | $1M |
| Gross Margin | 80.5% | 90.9% | 64.4% | 70.4% | 71.4% |
| R&D Expenses | $4M | $5M | $11M | $10M | $5M |
| SG&A Expenses | $2M | $2M | $3M | $3M | $3M |
| Operating Expenses | -$765K | $9M | $18M | $22M | $18M |
| Operating Income | -$9M | -$7M | -$17M | -$20M | -$16M |
| Operating Margin | -503.3% | -180.4% | -1186.1% | -1127.1% | -919.6% |
| Interest Expense | $959K | $1M | $2M | $66K | $313K |
| Income Before Tax | $722K | -$8M | -$19M | -$20M | -$24M |
| Tax Expense | $757K | $100K | $285K | $17K | $377K |
| Net Income | $1M | -$6M | -$20M | -$20M | -$24M |
| Net Margin | 61.3% | -146.2% | -1355.6% | -1130.2% | -1334.7% |
| EPS (Diluted) | $0.01 | $-0.07 | $-0.18 | $-0.15 | $-0.16 |
| EBITDA | $2M | -$6M | -$17M | -$18M | -$12M |
| Shares Outstanding | 76M | 88M | 106M | 136M | 154M |